⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CANF News
Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares
Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance
globenewswire.com
CANF
Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
globenewswire.com
CANF
Can-Fite’s Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study
globenewswire.com
CANF
Can-Fite’s Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study
globenewswire.com
CANF
Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson
globenewswire.com
CANF
Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy
globenewswire.com
CANF
Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson
globenewswire.com
CANF
Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson
globenewswire.com
CANF
AI-Driven Tele-Dermatoscopes Market Forecast to 2029 & 2034: Innovations Enhance Market Appeal with Industry Reaching $4.06 Billion by 2029
globenewswire.com
DGII
CANF
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX